nodes	percent_of_prediction	percent_of_DWPC	metapath
Hydrochlorothiazide—Pain in arm—Thalidomide—leprosy	0.0486	0.0546	CcSEcCtD
Hydrochlorothiazide—Electrolyte imbalance—Thalidomide—leprosy	0.0191	0.0215	CcSEcCtD
Hydrochlorothiazide—Raised liver function tests—Thalidomide—leprosy	0.0173	0.0194	CcSEcCtD
Hydrochlorothiazide—Sinus bradycardia—Thalidomide—leprosy	0.0163	0.0183	CcSEcCtD
Hydrochlorothiazide—Sexual dysfunction—Thalidomide—leprosy	0.0142	0.016	CcSEcCtD
Hydrochlorothiazide—Toothache—Thalidomide—leprosy	0.0131	0.0147	CcSEcCtD
Hydrochlorothiazide—KCNMA1—blood vessel—leprosy	0.0131	0.119	CbGeAlD
Hydrochlorothiazide—Serum creatinine increased—Thalidomide—leprosy	0.013	0.0146	CcSEcCtD
Hydrochlorothiazide—CA1—nerve—leprosy	0.0127	0.115	CbGeAlD
Hydrochlorothiazide—Hyperlipidaemia—Thalidomide—leprosy	0.0111	0.0124	CcSEcCtD
Hydrochlorothiazide—Muscular weakness—Dapsone—leprosy	0.00998	0.0112	CcSEcCtD
Hydrochlorothiazide—CA4—nerve—leprosy	0.00991	0.0903	CbGeAlD
Hydrochlorothiazide—Influenza—Dapsone—leprosy	0.00978	0.011	CcSEcCtD
Hydrochlorothiazide—Numbness—Thalidomide—leprosy	0.00962	0.0108	CcSEcCtD
Hydrochlorothiazide—Pancreatitis—Dapsone—leprosy	0.00959	0.0108	CcSEcCtD
Hydrochlorothiazide—Sensory loss—Thalidomide—leprosy	0.00921	0.0103	CcSEcCtD
Hydrochlorothiazide—Jaundice cholestatic—Thalidomide—leprosy	0.00908	0.0102	CcSEcCtD
Hydrochlorothiazide—Photosensitivity reaction—Dapsone—leprosy	0.00892	0.01	CcSEcCtD
Hydrochlorothiazide—Musculoskeletal stiffness—Thalidomide—leprosy	0.00889	0.00999	CcSEcCtD
Hydrochlorothiazide—Hyperuricaemia—Thalidomide—leprosy	0.0086	0.00966	CcSEcCtD
Hydrochlorothiazide—Neuropathy peripheral—Dapsone—leprosy	0.00855	0.0096	CcSEcCtD
Hydrochlorothiazide—Hypercholesterolaemia—Thalidomide—leprosy	0.00843	0.00948	CcSEcCtD
Hydrochlorothiazide—Bone pain—Thalidomide—leprosy	0.00833	0.00936	CcSEcCtD
Hydrochlorothiazide—Sinusitis—Dapsone—leprosy	0.00818	0.00919	CcSEcCtD
Hydrochlorothiazide—Blood uric acid increased—Thalidomide—leprosy	0.00812	0.00913	CcSEcCtD
Hydrochlorothiazide—Coordination abnormal—Thalidomide—leprosy	0.00812	0.00913	CcSEcCtD
Hydrochlorothiazide—Hyperkalaemia—Thalidomide—leprosy	0.00784	0.00881	CcSEcCtD
Hydrochlorothiazide—Pharyngitis—Dapsone—leprosy	0.00777	0.00873	CcSEcCtD
Hydrochlorothiazide—Blood urea increased—Thalidomide—leprosy	0.00753	0.00846	CcSEcCtD
Hydrochlorothiazide—Aplastic anaemia—Thalidomide—leprosy	0.00749	0.00841	CcSEcCtD
Hydrochlorothiazide—Tinnitus—Dapsone—leprosy	0.0073	0.0082	CcSEcCtD
Hydrochlorothiazide—Oesophagitis—Thalidomide—leprosy	0.00729	0.00819	CcSEcCtD
Hydrochlorothiazide—Pulmonary oedema—Thalidomide—leprosy	0.0071	0.00798	CcSEcCtD
Hydrochlorothiazide—KCNMA1—eye—leprosy	0.00698	0.0635	CbGeAlD
Hydrochlorothiazide—Erythema—Dapsone—leprosy	0.00681	0.00765	CcSEcCtD
Hydrochlorothiazide—CA12—eye—leprosy	0.00669	0.0609	CbGeAlD
Hydrochlorothiazide—Diabetes mellitus—Thalidomide—leprosy	0.00666	0.00748	CcSEcCtD
Hydrochlorothiazide—Photosensitivity—Thalidomide—leprosy	0.0066	0.00741	CcSEcCtD
Hydrochlorothiazide—Gastroenteritis—Thalidomide—leprosy	0.00653	0.00734	CcSEcCtD
Hydrochlorothiazide—Vascular purpura—Thalidomide—leprosy	0.00647	0.00727	CcSEcCtD
Hydrochlorothiazide—Vision blurred—Dapsone—leprosy	0.00642	0.00721	CcSEcCtD
Hydrochlorothiazide—Injury—Thalidomide—leprosy	0.0063	0.00708	CcSEcCtD
Hydrochlorothiazide—Libido decreased—Thalidomide—leprosy	0.00625	0.00702	CcSEcCtD
Hydrochlorothiazide—Increased appetite—Thalidomide—leprosy	0.00616	0.00692	CcSEcCtD
Hydrochlorothiazide—Dermatitis exfoliative—Thalidomide—leprosy	0.00614	0.00689	CcSEcCtD
Hydrochlorothiazide—Vertigo—Dapsone—leprosy	0.00612	0.00688	CcSEcCtD
Hydrochlorothiazide—Visual disturbance—Thalidomide—leprosy	0.00611	0.00687	CcSEcCtD
Hydrochlorothiazide—Atrial fibrillation—Thalidomide—leprosy	0.00611	0.00687	CcSEcCtD
Hydrochlorothiazide—Purpura—Thalidomide—leprosy	0.00601	0.00675	CcSEcCtD
Hydrochlorothiazide—CA9—tendon—leprosy	0.00599	0.0545	CbGeAlD
Hydrochlorothiazide—Arthritis—Thalidomide—leprosy	0.00596	0.00669	CcSEcCtD
Hydrochlorothiazide—Cough—Dapsone—leprosy	0.00595	0.00668	CcSEcCtD
Hydrochlorothiazide—Hyponatraemia—Thalidomide—leprosy	0.00581	0.00653	CcSEcCtD
Hydrochlorothiazide—Gastrointestinal haemorrhage—Thalidomide—leprosy	0.00579	0.00651	CcSEcCtD
Hydrochlorothiazide—Pain in extremity—Thalidomide—leprosy	0.00579	0.00651	CcSEcCtD
Hydrochlorothiazide—Disturbance in sexual arousal—Thalidomide—leprosy	0.00575	0.00645	CcSEcCtD
Hydrochlorothiazide—Migraine—Thalidomide—leprosy	0.0057	0.0064	CcSEcCtD
Hydrochlorothiazide—Affect lability—Thalidomide—leprosy	0.0057	0.0064	CcSEcCtD
Hydrochlorothiazide—Face oedema—Thalidomide—leprosy	0.00559	0.00628	CcSEcCtD
Hydrochlorothiazide—Mood swings—Thalidomide—leprosy	0.00549	0.00616	CcSEcCtD
Hydrochlorothiazide—Ataxia—Thalidomide—leprosy	0.00545	0.00612	CcSEcCtD
Hydrochlorothiazide—Tachycardia—Dapsone—leprosy	0.00543	0.0061	CcSEcCtD
Hydrochlorothiazide—Blood creatinine increased—Thalidomide—leprosy	0.00543	0.00609	CcSEcCtD
Hydrochlorothiazide—Liver function test abnormal—Thalidomide—leprosy	0.00535	0.00601	CcSEcCtD
Hydrochlorothiazide—Dry skin—Thalidomide—leprosy	0.00531	0.00596	CcSEcCtD
Hydrochlorothiazide—CA1—eye—leprosy	0.0053	0.0483	CbGeAlD
Hydrochlorothiazide—Orthostatic hypotension—Thalidomide—leprosy	0.00529	0.00594	CcSEcCtD
Hydrochlorothiazide—Hypokalaemia—Thalidomide—leprosy	0.00527	0.00592	CcSEcCtD
Hydrochlorothiazide—Breast disorder—Thalidomide—leprosy	0.00523	0.00588	CcSEcCtD
Hydrochlorothiazide—Aspartate aminotransferase increased—Thalidomide—leprosy	0.00522	0.00586	CcSEcCtD
Hydrochlorothiazide—Cramp muscle—Thalidomide—leprosy	0.00522	0.00586	CcSEcCtD
Hydrochlorothiazide—Toxic epidermal necrolysis—Thalidomide—leprosy	0.00522	0.00586	CcSEcCtD
Hydrochlorothiazide—Alanine aminotransferase increased—Thalidomide—leprosy	0.00511	0.00574	CcSEcCtD
Hydrochlorothiazide—Muscular weakness—Thalidomide—leprosy	0.00511	0.00574	CcSEcCtD
Hydrochlorothiazide—Abdominal distension—Thalidomide—leprosy	0.00504	0.00566	CcSEcCtD
Hydrochlorothiazide—Insomnia—Dapsone—leprosy	0.00503	0.00565	CcSEcCtD
Hydrochlorothiazide—Dysphagia—Thalidomide—leprosy	0.00501	0.00562	CcSEcCtD
Hydrochlorothiazide—Influenza—Thalidomide—leprosy	0.00501	0.00562	CcSEcCtD
Hydrochlorothiazide—CA9—testis—leprosy	0.00496	0.0452	CbGeAlD
Hydrochlorothiazide—Pancreatitis—Thalidomide—leprosy	0.00491	0.00551	CcSEcCtD
Hydrochlorothiazide—Angina pectoris—Thalidomide—leprosy	0.00488	0.00548	CcSEcCtD
Hydrochlorothiazide—Neutropenia—Thalidomide—leprosy	0.00468	0.00526	CcSEcCtD
Hydrochlorothiazide—Upper respiratory tract infection—Thalidomide—leprosy	0.00465	0.00523	CcSEcCtD
Hydrochlorothiazide—Pollakiuria—Thalidomide—leprosy	0.00462	0.00519	CcSEcCtD
Hydrochlorothiazide—Erectile dysfunction—Thalidomide—leprosy	0.00461	0.00518	CcSEcCtD
Hydrochlorothiazide—Photosensitivity reaction—Thalidomide—leprosy	0.00457	0.00513	CcSEcCtD
Hydrochlorothiazide—Weight increased—Thalidomide—leprosy	0.00456	0.00512	CcSEcCtD
Hydrochlorothiazide—Gastrointestinal pain—Dapsone—leprosy	0.00455	0.00511	CcSEcCtD
Hydrochlorothiazide—Hyperglycaemia—Thalidomide—leprosy	0.00452	0.00507	CcSEcCtD
Hydrochlorothiazide—Pneumonia—Thalidomide—leprosy	0.00449	0.00504	CcSEcCtD
Hydrochlorothiazide—Stevens-Johnson syndrome—Thalidomide—leprosy	0.00442	0.00497	CcSEcCtD
Hydrochlorothiazide—Acute coronary syndrome—Thalidomide—leprosy	0.0044	0.00494	CcSEcCtD
Hydrochlorothiazide—Abdominal pain—Dapsone—leprosy	0.0044	0.00494	CcSEcCtD
Hydrochlorothiazide—Body temperature increased—Dapsone—leprosy	0.0044	0.00494	CcSEcCtD
Hydrochlorothiazide—Renal failure—Thalidomide—leprosy	0.00439	0.00493	CcSEcCtD
Hydrochlorothiazide—Neuropathy peripheral—Thalidomide—leprosy	0.00437	0.00491	CcSEcCtD
Hydrochlorothiazide—Myocardial infarction—Thalidomide—leprosy	0.00437	0.00491	CcSEcCtD
Hydrochlorothiazide—Conjunctivitis—Thalidomide—leprosy	0.00434	0.00487	CcSEcCtD
Hydrochlorothiazide—Sweating—Thalidomide—leprosy	0.00428	0.00481	CcSEcCtD
Hydrochlorothiazide—Haematuria—Thalidomide—leprosy	0.00426	0.00478	CcSEcCtD
Hydrochlorothiazide—Epistaxis—Thalidomide—leprosy	0.00421	0.00473	CcSEcCtD
Hydrochlorothiazide—Sinusitis—Thalidomide—leprosy	0.00419	0.0047	CcSEcCtD
Hydrochlorothiazide—Agranulocytosis—Thalidomide—leprosy	0.00416	0.00468	CcSEcCtD
Hydrochlorothiazide—Bradycardia—Thalidomide—leprosy	0.00408	0.00458	CcSEcCtD
Hydrochlorothiazide—Rhinitis—Thalidomide—leprosy	0.00402	0.00451	CcSEcCtD
Hydrochlorothiazide—Hepatitis—Thalidomide—leprosy	0.00401	0.0045	CcSEcCtD
Hydrochlorothiazide—Hypoaesthesia—Thalidomide—leprosy	0.00399	0.00448	CcSEcCtD
Hydrochlorothiazide—Pharyngitis—Thalidomide—leprosy	0.00398	0.00447	CcSEcCtD
Hydrochlorothiazide—CA5B—tendon—leprosy	0.00397	0.0362	CbGeAlD
Hydrochlorothiazide—Oedema peripheral—Thalidomide—leprosy	0.00395	0.00443	CcSEcCtD
Hydrochlorothiazide—Visual impairment—Thalidomide—leprosy	0.00386	0.00434	CcSEcCtD
Hydrochlorothiazide—KCNMA1—testis—leprosy	0.00383	0.0348	CbGeAlD
Hydrochlorothiazide—Erythema multiforme—Thalidomide—leprosy	0.00379	0.00426	CcSEcCtD
Hydrochlorothiazide—KCNMA1—nervous system—leprosy	0.00375	0.0342	CbGeAlD
Hydrochlorothiazide—Tinnitus—Thalidomide—leprosy	0.00374	0.0042	CcSEcCtD
Hydrochlorothiazide—CA12—nervous system—leprosy	0.0036	0.0328	CbGeAlD
Hydrochlorothiazide—Arrhythmia—Thalidomide—leprosy	0.00358	0.00402	CcSEcCtD
Hydrochlorothiazide—Alopecia—Thalidomide—leprosy	0.00354	0.00398	CcSEcCtD
Hydrochlorothiazide—Vomiting—Dapsone—leprosy	0.00354	0.00397	CcSEcCtD
Hydrochlorothiazide—Headache—Dapsone—leprosy	0.00348	0.00391	CcSEcCtD
Hydrochlorothiazide—Flatulence—Thalidomide—leprosy	0.00344	0.00386	CcSEcCtD
Hydrochlorothiazide—CA2—eye—leprosy	0.00343	0.0313	CbGeAlD
Hydrochlorothiazide—Tension—Thalidomide—leprosy	0.00342	0.00384	CcSEcCtD
Hydrochlorothiazide—Dysgeusia—Thalidomide—leprosy	0.00342	0.00384	CcSEcCtD
Hydrochlorothiazide—Nervousness—Thalidomide—leprosy	0.00339	0.00381	CcSEcCtD
Hydrochlorothiazide—Back pain—Thalidomide—leprosy	0.00337	0.00379	CcSEcCtD
Hydrochlorothiazide—Muscle spasms—Thalidomide—leprosy	0.00335	0.00377	CcSEcCtD
Hydrochlorothiazide—Nausea—Dapsone—leprosy	0.0033	0.00371	CcSEcCtD
Hydrochlorothiazide—CA5B—testis—leprosy	0.00329	0.03	CbGeAlD
Hydrochlorothiazide—Vision blurred—Thalidomide—leprosy	0.00329	0.00369	CcSEcCtD
Hydrochlorothiazide—Tremor—Thalidomide—leprosy	0.00327	0.00367	CcSEcCtD
Hydrochlorothiazide—Ill-defined disorder—Thalidomide—leprosy	0.00324	0.00364	CcSEcCtD
Hydrochlorothiazide—CA5B—nervous system—leprosy	0.00323	0.0294	CbGeAlD
Hydrochlorothiazide—Anaemia—Thalidomide—leprosy	0.00322	0.00362	CcSEcCtD
Hydrochlorothiazide—Agitation—Thalidomide—leprosy	0.00321	0.0036	CcSEcCtD
Hydrochlorothiazide—Angioedema—Thalidomide—leprosy	0.00319	0.00358	CcSEcCtD
Hydrochlorothiazide—Malaise—Thalidomide—leprosy	0.00315	0.00353	CcSEcCtD
Hydrochlorothiazide—Vertigo—Thalidomide—leprosy	0.00313	0.00352	CcSEcCtD
Hydrochlorothiazide—Syncope—Thalidomide—leprosy	0.00313	0.00351	CcSEcCtD
Hydrochlorothiazide—Leukopenia—Thalidomide—leprosy	0.00312	0.00351	CcSEcCtD
Hydrochlorothiazide—Palpitations—Thalidomide—leprosy	0.00308	0.00346	CcSEcCtD
Hydrochlorothiazide—Loss of consciousness—Thalidomide—leprosy	0.00307	0.00344	CcSEcCtD
Hydrochlorothiazide—Cough—Thalidomide—leprosy	0.00304	0.00342	CcSEcCtD
Hydrochlorothiazide—CA2—skin of body—leprosy	0.00299	0.0272	CbGeAlD
Hydrochlorothiazide—Arthralgia—Thalidomide—leprosy	0.00297	0.00334	CcSEcCtD
Hydrochlorothiazide—Chest pain—Thalidomide—leprosy	0.00297	0.00334	CcSEcCtD
Hydrochlorothiazide—Myalgia—Thalidomide—leprosy	0.00297	0.00334	CcSEcCtD
Hydrochlorothiazide—Anxiety—Thalidomide—leprosy	0.00296	0.00332	CcSEcCtD
Hydrochlorothiazide—Discomfort—Thalidomide—leprosy	0.00293	0.0033	CcSEcCtD
Hydrochlorothiazide—Dry mouth—Thalidomide—leprosy	0.0029	0.00326	CcSEcCtD
Hydrochlorothiazide—Confusional state—Thalidomide—leprosy	0.00287	0.00322	CcSEcCtD
Hydrochlorothiazide—CA1—nervous system—leprosy	0.00285	0.026	CbGeAlD
Hydrochlorothiazide—Oedema—Thalidomide—leprosy	0.00285	0.0032	CcSEcCtD
Hydrochlorothiazide—Shock—Thalidomide—leprosy	0.0028	0.00315	CcSEcCtD
Hydrochlorothiazide—Thrombocytopenia—Thalidomide—leprosy	0.00279	0.00313	CcSEcCtD
Hydrochlorothiazide—Tachycardia—Thalidomide—leprosy	0.00278	0.00312	CcSEcCtD
Hydrochlorothiazide—Hyperhidrosis—Thalidomide—leprosy	0.00275	0.00309	CcSEcCtD
Hydrochlorothiazide—CA4—tendon—leprosy	0.00274	0.025	CbGeAlD
Hydrochlorothiazide—Anorexia—Thalidomide—leprosy	0.00271	0.00305	CcSEcCtD
Hydrochlorothiazide—Hypotension—Thalidomide—leprosy	0.00266	0.00299	CcSEcCtD
Hydrochlorothiazide—Musculoskeletal discomfort—Thalidomide—leprosy	0.00259	0.00291	CcSEcCtD
Hydrochlorothiazide—Insomnia—Thalidomide—leprosy	0.00257	0.00289	CcSEcCtD
Hydrochlorothiazide—Paraesthesia—Thalidomide—leprosy	0.00256	0.00287	CcSEcCtD
Hydrochlorothiazide—Dyspnoea—Thalidomide—leprosy	0.00254	0.00285	CcSEcCtD
Hydrochlorothiazide—Somnolence—Thalidomide—leprosy	0.00253	0.00284	CcSEcCtD
Hydrochlorothiazide—Dyspepsia—Thalidomide—leprosy	0.00251	0.00281	CcSEcCtD
Hydrochlorothiazide—Decreased appetite—Thalidomide—leprosy	0.00247	0.00278	CcSEcCtD
Hydrochlorothiazide—Fatigue—Thalidomide—leprosy	0.00245	0.00276	CcSEcCtD
Hydrochlorothiazide—Pain—Thalidomide—leprosy	0.00243	0.00273	CcSEcCtD
Hydrochlorothiazide—Constipation—Thalidomide—leprosy	0.00243	0.00273	CcSEcCtD
Hydrochlorothiazide—Feeling abnormal—Thalidomide—leprosy	0.00235	0.00263	CcSEcCtD
Hydrochlorothiazide—Gastrointestinal pain—Thalidomide—leprosy	0.00233	0.00261	CcSEcCtD
Hydrochlorothiazide—CA2—tendon—leprosy	0.00227	0.0207	CbGeAlD
Hydrochlorothiazide—CA4—testis—leprosy	0.00227	0.0207	CbGeAlD
Hydrochlorothiazide—Urticaria—Thalidomide—leprosy	0.00226	0.00254	CcSEcCtD
Hydrochlorothiazide—Body temperature increased—Thalidomide—leprosy	0.00225	0.00253	CcSEcCtD
Hydrochlorothiazide—Abdominal pain—Thalidomide—leprosy	0.00225	0.00253	CcSEcCtD
Hydrochlorothiazide—CA4—nervous system—leprosy	0.00223	0.0203	CbGeAlD
Hydrochlorothiazide—Hypersensitivity—Thalidomide—leprosy	0.0021	0.00236	CcSEcCtD
Hydrochlorothiazide—Asthenia—Thalidomide—leprosy	0.00204	0.00229	CcSEcCtD
Hydrochlorothiazide—Pruritus—Thalidomide—leprosy	0.00201	0.00226	CcSEcCtD
Hydrochlorothiazide—Diarrhoea—Thalidomide—leprosy	0.00195	0.00219	CcSEcCtD
Hydrochlorothiazide—CA2—testis—leprosy	0.00188	0.0172	CbGeAlD
Hydrochlorothiazide—Dizziness—Thalidomide—leprosy	0.00188	0.00211	CcSEcCtD
Hydrochlorothiazide—CA2—nervous system—leprosy	0.00185	0.0168	CbGeAlD
Hydrochlorothiazide—Vomiting—Thalidomide—leprosy	0.00181	0.00203	CcSEcCtD
Hydrochlorothiazide—Rash—Thalidomide—leprosy	0.00179	0.00202	CcSEcCtD
Hydrochlorothiazide—Dermatitis—Thalidomide—leprosy	0.00179	0.00201	CcSEcCtD
Hydrochlorothiazide—Headache—Thalidomide—leprosy	0.00178	0.002	CcSEcCtD
Hydrochlorothiazide—Nausea—Thalidomide—leprosy	0.00169	0.0019	CcSEcCtD
